Niche drugmaker ViroPharma attracts takeover interest: sources

By Jessica Toonkel NEW YORK (Reuters) – ViroPharma Inc, a drug maker specializing in rare diseases, is attracting preliminary acquisition interest from several pharmaceutical companies, according to three people familiar with the matter. No deal is imminent for the “orphan” drugmaker, which has a market capitalization of $1.8 billion, said two of the sources, who requested anonymity because they are not permitted to speak to the media. …